logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

TRULY INT'L (00732) repurchased 1 million shares for HK$795,000 on September 21.

date
16:42 21/09/2026
avatar
GMT Eight
TRULY INT'L (00732) announced that the company repurchased 1 million shares on September 21, 2026 for HK$795,000, at a repurchase price of HK$0.795 per share.
TRULY INT'L (00732) announced that on September 21, 2026, the company repurchased 1 million shares for HK$795,000, at a repurchase price of HK$0.795 per share.
Related Articles
HK Stock
CN INT DEV CORP (00264): Liang Weijie Appointed as Authorized Representative
China Stock
Shandong New Beiyang Information Technology (002376.SZ) subsidiary wins China Post outsourcing service project.
China Stock
Chongqing Pharscin Pharmaceutical (002907.SZ) received the approval notice for the supplementary drug application of Jian'er Xiaoshi Oral Liquid.
CN INT DEV CORP (00264): Liang Weijie Appointed as Authorized Representative
HK Stock
Shandong New Beiyang Information Technology (002376.SZ) subsidiary wins China Post outsourcing service project.
China Stock
Chongqing Pharscin Pharmaceutical (002907.SZ) received the approval notice for the supplementary drug application of Jian'er Xiaoshi Oral Liquid.
China Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.